CYP7A1 and obesity disorder: Colesevelam was previously found to suppress ileal Fgf15 expression due to its binding of bile acids, which subsequently derepresses hepatic Cyp7a1 expression via the Fxr–Fgf15–Cyp7a1 axis in a mouse model of high-fat diet-induced obesity [7], which we confirmed in our microbiome-humanized mice.